Ideaya Biosciences Inc (IDYA)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | RUIZ, BRISENO ANDRES | Chief Accounting Officer | Common Stock | Acquisition | 9,550 | 12.86 |
| Jul 7, 2026 | RUIZ, BRISENO ANDRES | Chief Accounting Officer | Stock Option (Right to Buy) | Disposal | 9,550 | 0 |
| Jul 7, 2026 | RUIZ, BRISENO ANDRES | Chief Accounting Officer | Common Stock | Disposal | 9,550 | 40.014 |
| Jun 16, 2026 | MORRISON, SCOTT W | Director | Stock Option (right to buy) | Acquisition | 20,000 | 0 |
| Jun 16, 2026 | ROSEN, TERRY J | Director | Stock Option (right to buy) | Acquisition | 20,000 | 0 |
| Jun 16, 2026 | YARNO, WENDY L | Director | Stock Option (right to buy) | Acquisition | 20,000 | 0 |
| Jun 16, 2026 | MACKEY, CATHERINE J | Director | Stock Option (right to buy) | Acquisition | 20,000 | 0 |
| Jun 16, 2026 | HAMPTON, MALCOLM GARRET | Director | Stock Option (right to buy) | Acquisition | 20,000 | 0 |
| Jun 16, 2026 | STEIN, JEFFREY | Director | Stock Option (right to buy) | Acquisition | 20,000 | 0 |
| Mar 2, 2026 | STEIN, JEFFREY | Director | Common Stock | Acquisition | 50,000 | 32.958 |
| Jan 30, 2026 | DORMAN, STUART | Chief Commercial Officer | Stock Option (right to buy) | Acquisition | 155,000 | 0 |
| Jan 30, 2026 | WHITE, MICHAEL ANTHONY | Chief Scientific Officer | Stock Option (right to buy) | Acquisition | 190,000 | 0 |
| Jan 30, 2026 | SNYDER, DOUGLAS B. | SVP, General Counsel | Stock Option (right to buy) | Acquisition | 130,000 | 0 |
| Jan 30, 2026 | BEAUPRE, DARRIN | Chief Medical Officer | Stock Option (right to buy) | Acquisition | 175,000 | 0 |
| Jan 30, 2026 | HATA, YUJIRO S | Director, President and CEO | Stock Option (right to buy) | Acquisition | 600,000 | 0 |
| Jan 30, 2026 | RUIZ, BRISENO ANDRES | See Remarks | Stock Option (right to buy) | Acquisition | 80,000 | 0 |
| Jan 30, 2026 | BLEHARSKI, JOSHUA | Chief Financial Officer | Stock Option (right to buy) | Acquisition | 170,000 | 0 |
| Nov 28, 2025 | RUIZ, BRISENO ANDRES | See Remarks | Common Stock | Acquisition | 1,253 | 16.907 |
| Nov 28, 2025 | SNYDER, DOUGLAS B. | SVP, General Counsel | Common Stock | Acquisition | 1,041 | 16.907 |